Efficacy of extended release Quetiapine Fumarate (Quetiapine XR) in patients with severe Major Depressive Disorder (MDD)

被引：0
|
作者：
Svedater, H. [1 ]
Thase, M. [2 ]
Locklear, J. [3 ]
Datto, C. [3 ]
机构：
[1] AstraZeneca R&D, Molndal, Sweden
[2] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
[3] AstraZeneca, Wilmington, DE USA
来源：
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 2009年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：43 / 44
页数：2
相关论文
共 50 条
  • [1] Extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S259 - S260
  • [2] POOLED ANALYSIS OF ADJUNCTIVE EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    El-Khalili, N.
    Bauer, M.
    Datto, C.
    Earley, W.
    Astrom, M.
    Eriksson, H.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [3] Sustained response with adjunctive extended release Quetiapine Fumarate (Quetiapine XR): pooled efficacy analysis in Major Depressive Disorder (MDD)
    Bauer, M.
    Vieta, E.
    Earley, W.
    Szamosi, J.
    Eriksson, H. A.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 24 - 24
  • [4] Efficacy of extended release quetiapine fumarate (quetiapine XR) monotherapy on sleep disturbance in patients with major depressive disorder
    Papakostas, G.
    Bandelow, B.
    Demyttenaere, K.
    Trivedi, M.
    Earley, W.
    Szamosi, J.
    Eriksson, H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 159 - 159
  • [5] Double-blind study of the efficacy and tolerability of extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in patients with major depressive disorder (MDD)
    Earley, W.
    McIntyre, A.
    Wang, G.
    Raines, S.
    Eriksson, H.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 332 - 332
  • [6] Efficacy and tolerability of once-daily extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in elderly patients with major depressive disorder (MDD)
    Katila, H.
    Mezhebovsky, I.
    Mulroy, A.
    Berggren, L.
    Datto, C.
    Eriksson, H.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 337 - 338
  • [7] Efficacy of extended release quetiapine fumarate (quetiapine XR) monotherapy and adjunct therapy in patients with major depressive disorder
    Kalali, A.
    Montgomery, S.
    Earley, W.
    Szamosi, J.
    Eriksson, H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 151 - 151
  • [8] Extended release Quetiapine Fumarate (Quetiapine XR) in acute and maintenance studies in Major Depressive Disorder (MDD): suicidality data
    Weisler, R.
    Montgomery, S. A.
    Eriksson, H. A.
    Szamosi, J.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 45 - 46
  • [9] ANALYSIS OF POOLED DATA: ONCE-DAILY EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) MONOTHERAPY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Montgomery, S.
    Weisler, R.
    Earley, W.
    Astrom, M.
    Lazarus, A.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [10] Effect of once-daily extended release Quetiapine Fumarate (Quetiapine XR) as add-on to antidepressants in major depressive disorder (MDD)
    Bauer, M.
    Pretorius, H. W.
    Earley, W.
    Lindgren, P.
    Brecher, M.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S243 - S243
12345